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Abstract
Objective
Vitamin B12 and folate are critical micronutrients needed to support the increased metabolic
demands of pregnancy. Recent studies from India have suggested that low vitamin B12 and
folate concentrations in pregnancy are associated with increased obesity; however differ-
ences in diet, antenatal vitamin supplementation, and socioeconomic status may limit the
generalisability of these findings. We aimed to explore the cross-sectional relationship of cir-
culating serum vitamin B12 and folate at 28 weeks’ gestation with maternal adiposity and
related biochemical markers in a white non diabetic UK obstetric cohort.
Methods
Anthropometry and biochemistry data was available on 995 women recruited at 28 weeks
gestation to the Exeter Family Study of Childhood Health. Associations between B12 and
folate with maternal BMI and other obesity-related biochemical factors (HOMA-R, fasting
glucose, triglycerides, HDL and AST) were explored using regression analysis, adjusting for
potential confounders (socioeconomic status, vegetarian diet, vitamin supplementation,
parity, haemodilution (haematocrit)).
Results
Higher 28 week BMI was associated with lower circulating vitamin B12 (r = -0.25; P<0.001)
and folate (r = -0.15; P<0.001). In multiple regression analysis higher 28 week BMI
remained an independent predictor of lower circulating B12 (β (95% CI) = -0.59 (-0.74,
-0.44) i.e. for every 1% increase in BMI there was a 0.6% decrease in circulating B12).
Other markers of adiposity/body fat metabolism (HOMA-R, triglycerides and AST) were
also independently associated with circulating B12. In a similar multiple regression AST
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was the only independent obesity-related marker associated with serum folate (β (95% CI)
= 0.16 (0.21, 0.51))
Conclusion
In conclusion, our study has replicated the previous Indian findings of associations between
lower serum B12 and higher obesity and insulin resistance during pregnancy in a non-dia-
betic White British population. These findings may have important implications for fetal and
maternal health in obese pregnancies.
Introduction
The rise in BMI in the general population is reflected in the more than doubling (7.6% to
15.6%) over the last 20 years of the proportion of women who are obese at the time of booking
with the maternity services[1]. These rising rates of obesity in pregnancy have led to an empha-
sis on understanding the effects of adiposity on maternal health. The paradox of nutritional
deficiencies in those who are overweight and obese[2] may have important implications for
maternal and fetal health and wellbeing in pregnancy.
The micronutrients B12 and folate are needed to support the increased demands of the fetus
in pregnancy. Both vitamins are involved in one-carbon metabolism and methylation pro-
cesses, including epigenetic modulation and DNA synthesis and repair, assisting the normal
processes of fetal growth and development. Deficiency of these vitamins is associated with
wide-ranging multi-system abnormalities, including megaloblastic anaemia in the mother, and
growth disturbances, birth defects and neurocognitive disorders in the offspring[3].
Lower B12 in pregnancy was associated with higher maternal BMI and/or increased off-
spring insulin resistance in a series from India[4–6], Given the differences in diet, antenatal
vitamin supplementation, and socioeconomic status, replication in a Western setting will help
generalisation of the finding.
The aim of our study was to investigate this relationship between maternal BMI and serum
vitamin B12 and folate in a UK pregnancy cohort. We studied the associations between circulat-
ing serum B12 and folate concentrations and measures of obesity and related glycaemic and met-
abolic biomarkers measured at 28 weeks gestation in non-diabetic, singleton, white pregnancies.
Methods
Subjects
Anthropometric measurements and biochemical data were available on 995 women recruited
as part of the Exeter Family Study of Childhood Health[7]. Height, weight, and fasting bloods
were taken at 28 weeks of pregnancy (+/-5 days). Routine analysis for fasting plasma glucose
(FPG) was undertaken by the pathology labs at the Royal Devon and Exeter NHS Foundation
Trust, UK (women with FPG>5.5 mmol/l were excluded from analysis). Serum insulin was
measured at the University Hospital Birmingham NHS Trust, UK using an immunochemilu-
minometric assay (Molecular Light Technology, Cardiff, UK). The assay is specific for insulin
and the interassay coefficients of variation were less than 9.0% over the concentration range
reported. Socio-economic status (SES) was based on post-code and determined by Townsend
deprivation score. Insulin resistance was calculated using the homeostatic model assessment
(HOMA)[8].
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B12 and folate measurements
B12 and folate were measured in serum samples taken at 28 weeks of pregnancy, and stored at
-80°C. B12 and folate were analysed with microbiological assays at the Diabetes Research Cen-
tre, KEM Hospital, Pune, India. Intra/inter-assay coefficients of variation were<8% for both
assays. Low B12 was defined as serum B12<150 pmol/l and low folate as<7 nmol/l, as previ-
ously described[5].
Statistics
Variables were assessed for normality and log transformations used where appropriate. Geo-
metric means and standard deviation (SD) range (+/- 1SD on the log scale, then back-trans-
formed) are therefore presented for these variables. T-tests were used to compare means.
Natural log transformation was used to aid interpretation of beta coefficients in regression
analysis (allowing regression coefficients to be interpreted in terms of percentage change[9]).
Pearson correlation coefficients were used to assess associations between the B12 and folate
results, and the measures of obesity and other metabolic parameters. Regression analysis was
used to explore the associations of BMI and obesity-related factors with B12 and folate, whilst
adjusting for potential confounders.
Ethics
All participants gave written informed consent. Ethical approval was granted by the North and
East Devon Research Ethics Committee.
Results
Baseline characteristics (Table 1)
995 women were recruited at 28 weeks of pregnancy. 26.4% had a BMI30kg/m2, 54.1% were
multiparous and 13.7% reported smoking in pregnancy. 90% of mothers took folic acid supple-
ments in early pregnancy (until 12 weeks gestation), 30% continued to take a multivitamin dur-
ing pregnancy and 8.5% were vegetarian.
Serum B12 and folate concentrations in pregnancy
The geometric mean (SD range) serum B12 concentration was 204.2 (141.3–295.1) pmol/l and
20% of the cohort had B12<150 pmol/l. The geometric mean (SD range) serum folate concen-
tration was 14.5 (7.6–27.5) nmol/l, and 14.7% of the cohort had folate concentrations<7
nmol/l. B12 concentration was positively correlated with folate concentration (r = 0.221,
p<0.001)
Higher maternal BMI was associated with lower B12 and folate
Higher BMI at 28 weeks pregnancy was associated with lower circulating serum vitamin B12
and folate (r = -0.252 and -0.151 respectively; P<0.001 for both). (Table 2)
Could these associations be explained by other factors?
To analyse potential confounders, the effects of maternal lifestyle factors, pregnancy factors,
and haemodilution, on vitamin B12 and folate were examined (Table 2)
B12 associations. In a univariate analysis lower B12 was seen in younger mothers and
those with higher social deprivation. B12 was higher in women who had taken vitamin supple-
ments during pregnancy (224 vs 195 pmol/l, p<0.001). There was no difference in B12
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concentrations between women who were vegetarian and those who were non-vegetarian (199.
vs 204pmol/l, p = 0.7). Haematocrit (a marker of ‘haemodilution’ in pregnancy) was positively
associated with B12 concentrations.
In a multiple regression analysis (Table 3), BMI, vitamin supplements and haematocrit were
the only factors that remained significantly associated with B12. Lower B12 concentrations
were associated with higher BMI, independently of maternal demographic and lifestyle factors,
pregnancy related factors, and haemodilution (Hct): Log BMI: β (95%CI) = -0.59 (-0.74, -0.44),
p<0.001). This suggests for every 1% increase in BMI there will be a 0.6% decrease in circulat-
ing B12.
Folate associations. In univariate analysis, lower folate was seen in younger mothers and
those with higher social deprivation scores. Folate concentrations were higher in women who
had taken vitamin supplements during pregnancy (22.9 v 12.0 nmol/l, p<0.001) and in vege-
tarians (23.4 v 13.8 nmol/l, p<0.001). Haematocrit (a marker of ‘haemodilution’ in pregnancy)
was positively associated with maternal folate concentrations (Table 2)
In a multiple regression analysis (Table 4) vegetarian diet, age, BMI, vitamin supplements
and parity remained significantly associated with folate. Lower folate concentrations were asso-
ciated with higher BMI, independently of these factors: Log BMI β (95%CI) = -0.42 (-0.65,
-0.19), p<0.001). This suggests for every 1% increase in BMI there will be a 0.4% decrease in
circulating folate.
Table 1. Baseline characteristics of study cohort (n = 995) at 28 weeks gestation.
Variables Mean +/- SD or*Geometric mean (SD range)
Micronutrient concentrations
- Serum B12 (pmol/L)* 204.2 (104.3–295.1)
- Serum Folate (nmol/L)* 14.5 (7.6–27.5)
Anthropometric measures
- BMI(kg/m2)* 27.5 (23.4–32.4)
Lifestyle/Demographics
- Age(yrs) 30.4 +/- 5.2
- Socio Economic Status (Townsend score) 0.3 +/- 3.1
- Smoking (%) 13.7
- Vegetarian (%) 8.5
- Multivitamin during pregnancy (%) 30
Pregnancy related factors
- Primiparity (%) 45.9
Haemodilution
- Haematocrit 34.1 +/- 2.6
BMI associated metabolic factors
- HOMA-R* 1.0 (0.8–2.2)
- Triglycerides (mmol/L) 2.0(1.5–2.8)
- HDL cholesterol 2.1 +/- 0.5
- AST (mmol/L)* 17.8 (13.8–22.9)
- FPG (mmol/L) 4.4 +/- 0.4
Data presented as mean +/- SD (or *geometric mean (SD range) for log transformed data). Discrete
variables presented as (%) for characteristic.
AST = Aspartate Aminotransferase.
doi:10.1371/journal.pone.0135268.t001
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Which factors associated with obesity explain the variation in B12 and
folate measurements?
In an attempt to understand potential mechanisms explaining the association between BMI,
and B12 and folate, we added other obesity-related factors (HOMA-R, fasting glucose, triglyc-
erides, HDL and AST) to the model (Table 5).
Table 5 shows the univariate associations of other obesity related factors with BMI, B12 and
folate. BMI was positively associated with HOMA-R, FPG, and Triglycerides, and negatively
with HDL and AST. B12 was negatively associated with HOMA-R, FPG, and Triglycerides and
positively with HDL and AST. Associations with folate were weaker than those with B12, with
only HOMA-R, HDL and AST remaining statistically significant.
B12 associations. In multiple regression analysis, the association between B12 and BMI
remained significant when adding in other obesity-related factors. HOMA-R, triglycerides, and
AST also explained variation in B12, independently of BMI (Table 6)).
Table 2. Univariate associations between B12, folate and BMI with potential confounders (lifestyle/demographic, pregnancy related and haemodi-
lutional factors) in 995 pregnant women. Pearson correlation coefficients (r) presented for continuous variables
Factor B12 Folate* 28 week BMI*
r (p) r (p) r (p)
BMI (kg/m2)* -0.25 (<0.001) -0.15 (<0.001) -
Lifestyle/demographic
- Age 0.09 (0.007) 0.20 (<0.001) -0.07 (0.02)
- Townsend Score -0.08 (0.008) -0.09 (0.003) 0.08 (0.009)
- Smoking -0.12 (<0.001 -0.22 (<0.001) 0.07 (0.026)
- Vegetarianism -0.01 (0.7) 0.24 (<0.001) -0.03 (0.3)
- Vitamin use 0.18 (<0.001) 0.50 (<0.001) -0.07 (0.025)
Pregnancy related
- Parity 0.07 (0.038) 0.18 (<0.001) -0.03 (0.3)
Haemodilutional
- Haematocrit (%) 0.15 (<0.001) 0.08 (0.01) 0.08 (0.018)
* denotes log transformed data
doi:10.1371/journal.pone.0135268.t002
Table 3. Multiple regression analysis to demonstrate the relationships between BMI and potential confounding variables on serum vitamin B12.
Partial R is the adjusted correlation coefficient.
Factors associated with serum vitamin B12* Partial R β 95% CI for β t p
BMI (kg/m2)* -0.25 -0.59 (-0.74, -0.44) 7.75 <0.001
Social/demographic
- age 0.03 0.002 (-0.003,0.007) 0.77 0.4
- Townsend score -0.03 -0.003 (-0.01, 0.004) -0.76 0.5
- smoking -0.05 -0.06 (-0.13, 0.01) -1.59 0.1
- vegetarianism -0.03 -0.04 (-0.12, 0.04) -0.93 0.4
- Vitamin use 0.14 0.11 (0.06, 0.16) 4.16 <0.001
Pregnancy related
- Parity 0.01 0.009 (-0.04, 0.06) 0.37 0.7
Haemodilutional
- Haematocrit (%) 0.15 2.11 (1.21, 3.01) 4.59 <0.001
*Denotes variable transformed using natural logs (allowing β coefﬁcients to be interpreted in terms of percentage change)
doi:10.1371/journal.pone.0135268.t003
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Folate associations. In a multiple regression analysis examining the associations between
folate and obesity-related factors, the pattern was less clear than seen with B12. BMI was no
longer an independent predictor of low folate. The obesity-associated factor explaining most of
the variation in folate was AST, with triglycerides and HDL also showing weak independent
associations (Table 7)).
Maternal BMI and interaction of folate and B12
We also investigated the association of maternal BMI with vitamin B12 and folate concentra-
tions simultaneously. Women with the lowest B12 and folate concentrations had the highest
BMI and those with highest B12 and folate concentrations had the lowest BMI (29.9 vs 25.8 kg/
m2, p<0.001) (Fig 1).
Discussion
In this first cross-sectional study in the UK we identified that higher BMI is associated with
lower circulating B12 and folate during pregnancy in a non-diabetic Caucasian British popula-
tion at 28 weeks gestation.
Table 4. Multiple regression analysis to demonstrate the relationships between BMI and potential confounding variables on serum folate. Partial
R is the adjusted Pearson correlation coefficient.
Factors associated with serum folate* Partial R Beta 95% CI t p
BMI (kg/m2)* -0.12 -0.42 (-0.65, -0.19) -3.63 <0.001
Social/demographic
- Age 0.16 0.02 (0.01, 0.03) 4.91 <0.001
- Townsend score -0.008 -0.001 (-0.01, 0.01) -0.23 0.8
- Smoking -0.09 -0.16 (-0.27, -0.05) -2.84 0.005
- Vegetarianism 0.18 0.36 (0.23, 0.49) 5.53 <0.001
- Vitamin use 0.41 0.54 (0.47, 0.62) 13.39 <0.001
Pregnancy related
- Parity 0.12 0.14 (0.07, 0.22) 3.72 <0.001
Haemodilutional
- Haematocrit (%) 0.07 1.58 (0.20, 2.96) 2.25 0.025
* Denotes variable transformed using natural logs (allowing β coefﬁcients to be interpreted in terms of percentage change)
doi:10.1371/journal.pone.0135268.t004
Table 5. Pearson correlation coefficients (r) to demonstrate the univariate associations between B12, folate and BMI with obesity relatedmetabolic
factors. Pearson correlation coefficients (r) presented for continuous variables
Factor B12* Folate* 28 week BMI
r (p) r (p) r (p)
Obesity related metabolic factors
- HOMAR* -0.22 (<0.001 -0.16 (<0.001) 0.53 (<0.001)
- FPG -0.09 (0.006) -0.04 (0.3) 0.30 (<0.001)
- Triglycerides* -0.21 (<0.001 -0.02 (0.5) 0.24 (<0.001)
- HDL 0.15 (<0.001) 0.14 (<0.001) -0.11 (<0.001)
- AST* 0.31 (<0.001) 0.23 (<0.001) -0.16 (<0.001)
*denotes log transformed data
doi:10.1371/journal.pone.0135268.t005
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Table 6. Multiple regression analysis to demonstrate the relationships between BMI, BMI associated factors, confounding variables and, haemodi-
lution on serum vitamin B12. Partial R is the adjusted pearson correlation coefficient.
Factors associated with serum vitamin B12* Partial R Beta 95% CI t p
BMI (kg/m2)* -0.15 -0.391 (-0.57, -0.21) -4.30 <0.001
BMI associated factors
- HOMAR* -0.09 -0.08 (-0.14, -0.02) -2.53 0.01
- Triglycerides (mmol/L)* -0.11 -0.12 (-0.20, -0.05) -3.20 0.001
- HDL Cholesterol 0.015 0.012 (-0.04, 0.06) 0.45 0.6
- AST (mmol/L)* 0.21 0.31 (0.22, 0.40) 6.4 <0.001
- FPG 0.024 0.025 (-0.04, 0.09) 0.71 0.48
Social/demographic
- Age -0.003 0 (-0.005, 0.005) 0.1 0.9
- Townsend score -0.014 -0.002 (-0.009, 0.006) -0.41 0.7
- smoking -0.011 -0.01 (-0.09, 0.06) 0.03 0.8
- Vegetarianism -0.03 -0.04 (-0.12, 0.04) -0.93 0.4
- Vitamin use 0.14 0.11 (0.06, 0.16) 4.2 <0.001
Pregnancy related
- Parity -0.008 -0.006 (-0.05, 0.04) -0.23 0.8
Haemodilutional
- Haematocrit (%) 0.12 1.66 (0.76, 2.56) 3.59 <0.001
* Denotes variable transformed using natural logs (allowing β coefﬁcients to be interpreted in terms of percentage change)
doi:10.1371/journal.pone.0135268.t006
Table 7. Multiple regression analysis to demonstrate the relationships between BMI, BMI associated factors, confounding variables and haemodi-
lution on serum vitamin folate.
Factors associated with serum folate* Partial R Beta 95% CI t p
BMI (kg/m2)* -0.06 -0.26 (-0.54, 0.02) -1.80 0.07
BMI associated factors
- HOMAR -0.05 -0.07 (-0.17, 0.03) -1.45 0.2
- Triglycerides (mmol/L) 0.07 0.12 (0.003, 0.239 2.01 0.05
- HDL cholesterol 0.07 0.09 (0.009, 0.17) 2.17 0.03
- AST (mmol/L)* 0.16 0.36 (0.21, 0.51) 4.7 <0.001
- FPG 0.006 0.01 (-0.10, 0.20) 0.18 0.9
Social/demographic
- Age 0.13 0.02 (0.008, 0.02) 3.82 <0.001
- Townsend score -0.02 -0.003 (-0.02, 0.008) -0.54 0.6
- Smoking -0.08 -0.13 (-0.25, -0.02) -2.26 0.02
- Vegetarianism 0.18 0.36 (0.23, 0.49) 5.45 <0.001
- Vitamin use 0.41 0.55 (0.47, 0.63) 13.30 <0.001
Pregnancy related
- Parity 0.09 0.11 (0.031, 0.18) 2.77 0.006
Haemodilutional
- Haematocrit (%) 0.04 0.94 (-0.49, 2.38) 1.29 0.2
* Denotes variable transformed using natural logs (allowing β coefﬁcients to be interpreted in terms of percentage change)
doi:10.1371/journal.pone.0135268.t007
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The inverse association of vitamin B12 in pregnancy with obesity and insulin resistance is in
keeping with the previous study from India[4]. The British women in our cohort had higher
serum B12 levels and lower folate concentrations at 28 weeks gestation (201 vs 162 pmol/l and
14 vs 35nmol/l respectively) compared to Indian mothers when measured in the identical
assay. This resulted in fewer with low B12 (<150 pmol/L) (20% vs 43%) but more with low
folate (<7nmol/L) (15% vs 4%). The British mothers were non-diabetic, heavier, older and pre-
dominantly non-vegetarian. Despite these differences, we observed that lower circulating B12
was associated with higher BMI and insulin resistance, suggesting that these associations are
more general and not only restricted to the Indian population with its vegetarian dietary
habits.
We have shown that the association of higher BMI with lower B12 is unlikely to be the result
of the potential confounding effects of demographic, lifestyle, pregnancy, or haemodilutional
factors, suggesting it could be the result of obesity in pregnancy itself. We explored the associa-
tions of BMI related biochemical indices with vitamin B12 and folate. BMI remains an inde-
pendent predictor of circulating B12, as do HOMA-R, triglycerides and AST. These indices are
markers of adiposity/body fat metabolism and support the hypothesis that altered maternal
body fat distribution/metabolism during pregnancy may be implicated in determining circulat-
ing concentrations of micronutrients in pregnancy.
Vitamin B12 and folate are essential for cell growth and maintenance, and play crucial roles
during fetal development. Our findings suggest that increasing maternal obesity in mothers
may result in a reduction in circulating concentrations of essential micronutrients needed by
both mother and her fetus. The increasing evidence of the role of one-carbon metabolism
(important for the synthesis of nucleic acids and DNAmethylation) in fetal growth and pro-
gramming of non-communicable diseases has been summarised recently[10]. The fetuses of
obese mothers are known to be at increased risk of a range of malformations, including neural
tube defects and cardiovascular abnormalities. Our findings raise the possibility that these
could be mediated by low levels of vitamin B12 and folate which are known to be involved in
these processes[11], and if confirmed would strengthen the evidence in favour of special needs
of vitamin supplementation for obese women planning to become pregnant. To confirm this
Fig 1. Association of maternal BMI with vitamin B12 and folate concentrations (tertiles). Bars represent
geometric mean BMI for each group.
doi:10.1371/journal.pone.0135268.g001
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would require larger studies, including interventional studies, measuring B12 and folate in the
first trimester.
Our study has several limitations: it is a cross sectional study with measures of B12 and
folate at one time point only, therefore our findings may not be representative of the crucial
early stages of pregnancy or late trimester. We suggest future studies should include longitudi-
nal sequential sampling from early gestation. Residual confounding by socio-economic status
and dietary factors is possible because women with lower B12 and folate concentrations were
younger, more obese and more socially deprived. A recent review suggested that the micronu-
trient deficiencies associated with overweight and obesity may result from increased intake of
relatively cheap, energy dense but nutrient poor foods[12].
We have identified associations but these do not define a causal relationship or its direction.
These issues could be investigated further by the use of animal models, by future RCT studies
on the effects of micronutrition on pregnancy and gestational development, or by using the
technique of Mendelian randomisation employing genetic variants associated with vitamin
B12 and folate.
In conclusion, our study has replicated the previous Indian findings of associations between
lower serum B12 and higher obesity and insulin resistance during pregnancy in a non-diabetic
White British population. These findings may have important implications for fetal and mater-
nal health in obese pregnancies.
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